Total Payments
$2,348
2024 Payments
$25.14
Companies
22
Transactions
160
Medicare Patients
3,810
Medicare Billing
$303,722
Payment Breakdown by Category
Food & Beverage$2,338 (99.6%)
Education$10.11 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,338 | 158 | 99.6% |
| Education | $10.11 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $333.17 | 20 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $287.72 | 24 | $0 (2019) |
| Novo Nordisk Inc | $201.59 | 12 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $197.08 | 15 | $0 (2019) |
| Astellas Pharma US Inc | $196.91 | 13 | $0 (2019) |
| PFIZER INC. | $190.77 | 18 | $0 (2019) |
| Allergan Inc. | $180.16 | 6 | $0 (2018) |
| Amgen Inc. | $132.48 | 8 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $113.55 | 8 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $89.43 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.14 | 1 | Blueprint Medicines Corporation ($25.14) |
| 2019 | $234.10 | 16 | GlaxoSmithKline, LLC. ($35.12) |
| 2018 | $1,036 | 63 | AstraZeneca Pharmaceuticals LP ($157.72) |
| 2017 | $1,053 | 80 | AstraZeneca Pharmaceuticals LP ($158.83) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $25.14 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/14/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: UROLOGY | ||||||
| 07/23/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/16/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/01/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 06/25/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Respiratory | ||||||
| 04/25/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: Neuroscience | ||||||
| 02/26/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: UROLOGY | ||||||
| 02/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diabetes | ||||||
| 01/31/2019 | PFIZER INC. | CHANTIX (Drug), LYRICA, COLOGUARD | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/29/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $23.24 | General |
| Category: AED | ||||||
| 01/28/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: DIABETES | ||||||
| 01/17/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/09/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: DIABETES | ||||||
| 12/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/10/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: UROLOGY | ||||||
| 12/05/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2018 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Respiratory | ||||||
| 11/05/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 459 | 610 | $150,336 | $53,825 |
| 2022 | 15 | 1,393 | 2,152 | $268,424 | $102,572 |
| 2021 | 14 | 959 | 1,410 | $181,795 | $72,942 |
| 2020 | 14 | 999 | 1,322 | $242,148 | $74,384 |
Total Patients
3,810
Total Services
5,494
Medicare Billing
$303,722
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 318 | $73,776 | $27,052 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 121 | $20,570 | $7,602 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $20,650 | $7,266 | 35.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 40 | 47 | $23,312 | $7,030 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 15 | $4,530 | $1,935 | 42.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,840 | $1,551 | 26.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $756.00 | $740.88 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $902.00 | $647.90 | 71.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 369 | 600 | $142,092 | $47,864 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 284 | $47,053 | $15,597 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $27,285 | $13,743 | 50.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 97 | 97 | $10,379 | $6,648 | 64.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 26 | 26 | $9,776 | $4,281 | 43.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 26 | $8,528 | $3,411 | 40.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 100 | 100 | $4,600 | $2,829 | 61.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 331 | 795 | $7,155 | $2,353 | 32.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 14 | $4,424 | $2,261 | 51.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $2,592 | $1,595 | 61.5% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 27 | 27 | $2,160 | $1,010 | 46.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $690.00 | $429.86 | 62.3% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 11 | 11 | $880.00 | $418.84 | 47.6% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 23 | 23 | $690.00 | $98.13 | 14.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 15 | $120.00 | $33.34 | 27.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 262 | 408 | $96,661 | $35,678 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 164 | 206 | $34,086 | $13,084 | 38.4% |
About Dr. Thomas Kohl, MD
Dr. Thomas Kohl, MD is a Sports Medicine healthcare provider based in Lebanon, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265425706.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Kohl, MD has received a total of $2,348 in payments from pharmaceutical and medical device companies, with $25.14 received in 2024. These payments were reported across 160 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,338).
As a Medicare-enrolled provider, Kohl has provided services to 3,810 Medicare beneficiaries, totaling 5,494 services with total Medicare billing of $303,722. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Lebanon, PA
- Active Since 08/30/2005
- Last Updated 05/05/2021
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1265425706
Products in Payments
- JARDIANCE (Drug) $156.52
- SYMBICORT (Drug) $155.29
- FARXIGA (Drug) $145.27
- MYRBETRIQ (Drug) $120.70
- Prolia (Biological) $117.77
- ENTRESTO (Drug) $113.55
- VRAYLAR (Drug) $112.74
- Victoza (Drug) $108.76
- Myrbetriq (Drug) $76.21
- Ozempic (Drug) $75.41
- Trintellix (Drug) $75.28
- PRALUENT (Drug) $75.08
- CHANTIX (Drug) $63.70
- XARELTO (Drug) $58.82
- TOUJEO (Drug) $54.94
- SOLIQUA (Drug) $51.90
- BYSTOLIC (Drug) $51.43
- TRELEGY ELLIPTA (Drug) $50.14
- EUCRISA (Drug) $46.28
- STIOLTO RESPIMAT (Drug) $40.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Lebanon
Martha George, Md, MD
Sports Medicine — Payments: $18,334
Sports Medicine $18,334
Jonathan Cornelius, Md, MD
Sports Medicine — Payments: $3,471
Sports Medicine $3,471
Dr. Charles Carr, Md, MD
Sports Medicine — Payments: $1,200
Sports Medicine $1,200
Daniel Kraft, Md, MD
Sports Medicine — Payments: $416.77
Sports Medicine $416.77
Jitesh Umarvadia, M.d, M.D
Sports Medicine — Payments: $44.66
Sports Medicine $44.66
Dr. Blake Corcoran, M.d, M.D
Sports Medicine — Payments: $43.21
Sports Medicine $43.21